Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. 2015
  2. Published

    Retinal vascular and structural dynamics during acute hyperglycaemia

    Klefter, O. N., Vilsbøll, Tina, Knop, Filip Krag & Larsen, Michael, Dec 2015, In: Acta Ophthalmologica. 93, 8, p. 697-705 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis

    Gyldenløve, M., Vilsbøll, Tina, Zachariae, Claus, Holst, Jens Juul, Knop, Filip Krag & Skov, Lone, 11 Nov 2015, In: Journal of Internal Medicine. 278, 6, p. 660-70 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis

    Junker, A. E., Gluud, Lise Lotte, Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, Tina, Oct 2015, In: Journal of Gastroenterology and Hepatology. 30, 10, p. 1522-8 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young

    Østoft, S. H., Bagger, J. I., Hansen, Torben, Hartmann, Bolette, Pedersen, Oluf Borbye, Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, Tina, 1 Aug 2015, In: European Journal of Endocrinology. 173, 2, p. 205-215 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide

    Vedtofte, L., Knop, Filip Krag & Vilsbøll, Tina, 1 May 2015, In: Expert Review of Clinical Pharmacology. 8, 3, p. 273-282 10 p.

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide

    Vedtofte, L., Knop, Filip Krag & Vilsbøll, Tina, 1 May 2015, In: Expert Review of Clinical Pharmacology. 8, 3, p. 273-282 10 p.

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    Sevelamer in a diabetologist's perspective: A phosphate-binding resin with glucose-lowering potential

    Brønden, Andreas, Hansen, M., Sonne, David Peick, Rohde, U., Vilsbøll, Tina & Knop, Filip Krag, 1 Feb 2015, In: Diabetes, Obesity and Metabolism. 17, 2, p. 116-120 5 p.

    Research output: Contribution to journalReviewResearchpeer-review

  9. Published

    Sevelamer in a diabetologist's perspective: A phosphate-binding resin with glucose-lowering potential

    Brønden, Andreas, Hansen, M., Sonne, David Peick, Rohde, U., Vilsbøll, Tina & Knop, Filip Krag, 1 Feb 2015, In: Diabetes, Obesity and Metabolism. 17, 2, p. 116-120 5 p.

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes-focus on pancreatitis and pancreas cancer

    Chalmer, T., Almdal, Thomas Peter, Vilsbøll, Tina & Knop, Filip Krag, 2015, In: Expert Opinion on Drug Safety. 14, 1, p. 171-180

    Research output: Contribution to journalReviewResearchpeer-review

  11. Published

    Plasma YKL-40 during pregnancy and gestational diabetes mellitus

    Rinnov, A. R., Rathcke, C. N., Bonde, L., Vilsbøll, Tina & Knop, Filip Krag, 2015, In: Journal of Reproductive Immunology. 112, p. 68-72

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 33056950